Novalung ultimate kit (US)
Extracorporeal System For Long-Term Respiratory / Cardiopulmonary Failure. 510(k) K232926, from Fresenius Medical Care Renal Therapies Group, LLC (Waltham, MA). Product code QJZ, class 2.
As of Nov 21, 2026, K232926 is an FDA 510(k) held by Fresenius Medical Care Renal Therapies Group, LLC, substantially equivalent on Apr 15, 2024 after 208 days, with no recalls tied to it in FDA's recall database.
- Review time: 208 days
- Recalls: 0
The Novalung System is indicated for long-term (> 6 hours) respiratory/cardiopulmonary support that provides assisted extracorporeal circulation and physiologic gas exchange (oxygenation and CO2 removal) of the patient's blood in adults with acute respiratory failure or acute cardiopulmonary failure, where other available treatment options have failed, and continued clinical deterioration is…
- Novalung SystemK191407 · Fresenius Medical Care Renal Therapies Group, LLC · Feb 21, 2020
- VitalFlow Set with Balance™ BiosurfaceK261335 · Medtronic, Inc. · Jul 31, 2026
- VitalFlow Set with Balance BiosurfaceK240880 · Medtronic, Inc. · Sep 12, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 20, 2023
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.4100
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files